Clobetasol Propionate

Overview

Clobetasol Propionate is a synthetic corticosteroid used primarily in dermatology to reduce inflammation and itching associated with various skin conditions. It is highly potent and is often prescribed for short-term use only due to potential systemic side effects.

API suppliers (13)

Suppliers of Clobetasol Propionate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• NEWCHEM SPAItaly1 active DMF GMP on record
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• ENVEE DRUGS PVT LTDIndia1 active DMF
• RN LABORATORIES EUROPE BVNetherlands1 active DMF
• TAPI NL BVNetherlands1 active DMF
• FARMABIOS SPAItaly1 active DMF
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• SYMBIOTEC PHARMALAB LTD1 active DMF GMP on record
• CESQUISA SA
• MAHIMA LIFE SCIENCES PRIVATE LTDIndia
• GlaxoSmithKline plcUnited Kingdom GMP on record
• Teva Pharmaceutical Industries Ltd.Israel GMP on record

EU CEP holders (5)

Companies holding a valid EU Certificate of Suitability (CEP) for Clobetasol Propionate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (58 approved US products), the latest listed US patent on Clobetasol Propionate expires 9 May 2036 and exclusivity 4 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas